Proposed LCD DL40427: MolDX: Next-Generation Sequencing for Hematologic Malignancies and Suspected Hematologic Malignancies — Noridian
Policy LCD-DL40427 · Oncology
Proposed LCD: NGS coverage for hematologic malignancies—comment by 10/11/26
Code intelligence
0242U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0242U.
Critical code risk
Signal breakdown
4 shown · 4 total in platform
Risk: Critical
1
Critical
25%
3
High
75%
0
Routine
0%
0
Low
0%
New this month
+1
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Critical
LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
Audit documentation
Building an audit file that includes 0242U?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription